The analysis of the entire cohort and individual NSCLC subtypes showed no statistically significant differences in the cytoplasmic expression of BCL11A in relation to sex, age, primary tumor size (T), lymph node metastasis status (N) and cancer stage (Table 2). This evidence concerns the gene BCL11A and neoplasm.